Improvement of family caregivers’ knowledge of polypharmacy in the elderly after health education

Authors

  • Mustaming Mustaming POLTEKKES KEMENKES KALIMANTAN TIMUR
  • Rina Loriana Jurusan Keperawatan, Poltekkes Kemenkes Kalimantan Timur
  • Azhari Azhari Jurusan Analis Kesehatan, Poltekkes Kemenkes Kalimantan Timur
  • Badar Badar Jurusan Keperawatan, Poltekkes Kemenkes Kalimantan Timur

DOI:

https://doi.org/10.12928/pharmaciana.v8i1.7944

Keywords:

elderly, family caregiver, health education, polypharmacy

Abstract

The different health problems in elderly patients require complex management. However, if the use of medicines is uncontrolled, it will lead to polypharmacy. This study aimed to analyze the effect of health education on family caregivers’ knowledge of polypharmacy particularly to prevent drug therapy problem in elderly patients. This quasi-experimental study used one-group pre-test post-test design. The population was family caregivers who had elderly members in their care and lived within the working area of Bengkuring Public Health Center. The population members were selected according to the inclusion criteria until a minimum sample size was reached. Having met the criteria, the respondents were asked to fill in a pre-test questionnaire before they partook in the health education for polypharmacy and a post-test questionnaire after their participation. The pre-test and post-test information were then analyzed using a paired t-test. This study revealed that the family caregivers’ knowledge of polypharmacy improved by 32.5% with a probability value (p= 0.000< 0.001) less than the level of significance (5%). The contribution of the health education to the family caregivers’ knowledge of polypharmacy was 74.3%. There was an improvement in the family caregivers’ knowledge of polypharmacy after participating in the health education.

References

Ahmed, B. et al., 2014. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care Hospital in Karachi: A prospective cohort study. PLoS ONE, 9(11), pp.1–8.

Andriane, Y., Sastramihardja, H.S. & Ruslami, R., 2016. Determinan Peresepan Polifarmasi pada Resep Rawat Jalan di Rumah Sakit Rujukan. Global Medical & Health Communication, 4(1), pp.66–74.

Bushardt, R.L. et al., 2008. Polypharmacy: Misleading, but manageable. Clinical Interventions in Aging, 3(2), pp.383–389.

Hanlon JT, Handler S, Maher R, S.K., 2008. Geriatric Pharmacotherapy and Polypharmacy .In: Fillit H, Rockwood K, Woodhouse K, eds. Bracklehurst ’ s Textbook of Geriatric Medicine 7th Ed. Churchil Livingstone

Jorgensen, T. et al., 2001. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Annals of Pharmacotherapy, 35(9), pp.1004–1009.

Kementrian Kesehatan RI, 2013. Gambaran kesehatan lanjut usia. Pusat data & Informasi.

Kim, H.A. et al., 2014. Prevalence and predictors of polypharmacy among Korean elderly. PLoS ONE, 9(6).

Muljabar, S.M. & Supadmi, W., 2014. Pengaruh Pemberian Informasi Obat Terhadap Tingkat Kepatuhan Penggunaan Antibiotika pada Pasien ISPA di Puskesmas Kotagede I Yogyakarta. Pharmaciana, 4(2), pp.143–149.

Notoatmodjo, S., 2012. Promosi Kesehatan dan perilaku kesehatan, Jakarta: Rineka Cipta.

Nursalam, 2008. Konsep dan Penerapan Metodelogi Penelitian Ilmu Keperawatan, Jakarta: Salemba Medika.

Rahmawati, Y. & Sunarti, S., 2014. Permasalahan Pemberian Obat pada Pasien Geriatri di Ruang Perawatan RSUD Saiful Anwar Malang. Jurnal Kedokteran Brawijaya, 28(2), pp.140–144.

Stewart, R.B. & Cooper, J.W., 1994. Polypharmacy in the Aged: Practical Solutions. Drugs & Aging, 4(6), pp.449–461.

Viktil, K.K. et al., 2007. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. British Journal of Clinical Pharmacology, 63(2), pp.187–195.

Downloads

Published

2018-06-02

Issue

Vol. 8 No. 1 (2018): Pharmaciana

Section

Clinical and Community Pharmacy

License

Authors who publish with Pharmaciana agree to the following terms:

  1. Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal. 
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.